A recent study found that granulocyte-macrophage colony-stimulating factor (GM-CSF) alleviated pulmonary fibrosis by reducing the incidence of EMT by inhibiting the production of inflammatory cytokines such as TGF-β, TNF-α, IL-1β, and IL-6. This evidence concerns the gene CSF2 and pulmonary fibrosis.